October 28, 2014

he Food and Drug Administration last week announced approval for Obizur for the treatment of bleeding episodes in adults with acquired hemophilia A. 

September 16, 2014

Baxter International announced that the Food and Drug Adminsitration approved Rixubis [coagulation factor IX (recombinant)] for the treatment, control and prevention of bleeding episodes, as well as perioperative management, in children with hemophilia B. 

July 7, 2014

Novo Nordisk on Monday announced that the Food and Drug Administration approved the company's NovoSeven RT (coagulation factor VIIa [recombinant]).

June 9, 2014

A recently approved drug might make infusions for hemophiliacs fewer and further between. The Food and Drug Administration approved Biogen Idec's Eloctate, which clinical trials have shown works to treat bleeding episodes and to increase the time between prophylactic blood infusions for those with hemophilia A.

May 12, 2014

Bayer HealthCare on Monday announced that the Food and Drug Administration approved the company's new indication for Bayer's Kogenate FS antihemophilic factor VIII (recombinant) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.

May 9, 2014

The Food and Drug Administration on Thursday approved Zontivity (vorapaxar) tablets, an anti-platelet agent that's designed to decrease the tendency of platelets to clump together to form a blood clot.

February 10, 2014

Women who take aspirin daily may reduce their risk of ovarian cancer by 20%, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health.

December 23, 2013

Two experimental drugs under development by Biogen Idec are effective in reducing bleeding episodes in patients with two forms of hemophilia when administered as a preventive treatment, while also reducing the need for frequent injections, according to late-stage clinical trial data.

December 23, 2013

The Food and Drug Administration has approved a new treatment made by Danish drug maker Novo Nordiskfor a rare, genetic bleeding disorder, the agency said Monday.

October 24, 2013

A mobile app described as the specialty pharmacy industry's first for patients with hemophilia has become available.

October 17, 2013

The Food and Drug Administration has approved a new drug made by Novo Nordisk for treating hemophilia A, the Danish drug maker said.

June 27, 2013

The Food and Drug Administration has approved what's being called the first therapy of its kind to prevent bleeding episodes.

June 6, 2013

Recent data suggests that aspirin may be effective for reducing cancer deaths in addition to preventing heart attacks, raising the question whether the combined health benefits outweigh the risks of gastrointestinal bleeding and stroke for middle-aged men, researchers announced Wednesday.

December 5, 2012

Patients once considered "aspirin resistant" may not be resistant to aspirin after all, according to a study published online by Circulation, the journal of the American Heart Association. Rather, the protective coating around the aspirin to prevent stomach issues may be delaying the absorption of aspirin, leading clinicians to believe that patients are aspirin resistant.

November 28, 2012

Novo Nordisk has launched a mobile app for hemophilia patients, the drug maker said.

November 8, 2012

Recent research from the Rothman Institute at Jefferson has shown aspirin to be just as effective in preventing clots — specifically pulmonary emboli, life-threatening blood clots that can develop in the arteries of the lungs following joint replacement surgery — Thomas Jefferson University announced Wednesday.

July 11, 2012

Days after its acquisition of Coagulife, specialty pharmacy provider BioRx has received limited distribution rights to a treatment for a bleeding disorder described as one of the rarest in the world.

July 9, 2012

Specialty pharmacy provider BioRx has acquired another specialty pharmacy provider based in Minnesota, BioRx said Monday.

May 29, 2012

BioPlus Specialty Pharmacy has appointed a new person to head its bleeding disorders program, the company said Tuesday.

February 7, 2012

A drug under development by Merck "significantly" reduced the risk of heart attack, stroke and cardiovascular death in patients, according to clinical trial results announced Tuesday.

December 7, 2011

Aspirin taken within five days before cardiac surgery is associated with a significant decrease in the risk of major postoperative complications, including renal failure, an intensive care unit stay, and even early death (30-day mortality), according to findings from an observational cohort study by researchers at Thomas Jefferson University and the University of California Davis Medical Center that are set to appear in the journal Annals of Surgery.

February 24, 2011

Novo Nordisk has filed for approval of a treatment for a rare genetic bleeding disorder, the Danish drug maker said Wednesday.

August 2, 2010

The Food and Drug Administration has given orphan drug designation to a treatment for an...

June 27, 2010

Bayer HealthCare Pharmaceuticals has launched a free mobile application for patients with hemophilia, the drug...